SARS-CoV-2,
Showing 51 - 75 of >10,000
COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)
Active, not recruiting
- COVID-19
- Experimental: Primary Cohort
- Placebo Comparator: Primary Cohort - Placebo
-
Chicago, IllinoisUniversity of Chicago
Aug 24, 2023
Humoral and Cellular Immunity in First-cycle SARS-CoV-2
Completed
- SARS CoV 2 Infection
- COVID-19
- LIAISON SARS-CoV-2 TrimericS IgG (DiaSorin)
- +2 more
-
Catanzaro, ItalyAOU Mater Domini
Jul 15, 2022
Covid19, SARS-COV-2 Infection Trial (DWJ1248, Placebo)
Terminated
- Covid19
- SARS-COV-2 Infection
- DWJ1248
- Placebo
-
Seoul, Korea, Republic ofSamsung Medical Center
Dec 4, 2022
Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster
Terminated
- Anti-SARS-CoV-2 Antibody Response
- blood and saliva samples will be taken
-
Graz, AustriaMedizinische Universität Graz, Klinische Abteilung für Rheumatol
Jan 9, 2023
Sustained Immunity to COVID-19 as Measured by SARS-CoV-2
Recruiting
- Covid19
- Serologic immunoassays to SARS-CoV-2 antibodies
-
Detroit, MichiganHenry Ford Health System
Dec 13, 2022
Vitamin D and Vitamin D Binding Protein With Disease Severity in
Active, not recruiting
- SARS CoV-2 Infection
- Vitamin D Binding protein
-
Istanbul, TurkeyHaseki Training and Research Hospital
Nov 1, 2022
COVID-19 Trial in Shang Qiu (low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell), high-dose Recombinant SARS-CoV-2 Vaccine (CHO
Active, not recruiting
- COVID-19
- low-dose Recombinant SARS-CoV-2 Vaccine (CHO cell)
- +2 more
-
Shang Qiu, He Nan, ChinaNing ling Center for Disease Control and Prevention
Jan 31, 2023
HIV Seropositivity, Immunodeficiency, Vaccination Reaction Trial in Ghent (Blood draw)
Recruiting
- HIV Seropositivity
- +3 more
- Blood draw
-
Ghent, East Flanders, BelgiumUH Ghent
Jan 4, 2023
COVID-19 Vaccine Trial in Bangkok (25 Baiya SARS-CoV-2 Vax 2, 50 Baiya SARS-CoV-2 Vax 2)
Active, not recruiting
- COVID-19 Vaccine
- 25 Baiya SARS-CoV-2 Vax 2
- 50 Baiya SARS-CoV-2 Vax 2
-
Bangkok, ThailandQueen Saovabha Memorial Institute
Aug 8, 2022
SARS CoV 2 Infection, COVID-19 Trial in Brussels (Humoral immunity)
Enrolling by invitation
- SARS CoV 2 Infection
- COVID-19
- Humoral immunity
-
Brussels, BelgiumSciensano
Jan 16, 2023
SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease
Not yet recruiting
- Metabolic Associated Fatty Liver Disease
- Recombinant protein vaccine and adenovirus vector vaccine
- (no location specified)
Feb 12, 2023
SARS-CoV-2, Safety, Immunotoxicity Trial in Wuhan (one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006), Cellular Immunity,
Not yet recruiting
- SARS-CoV-2
- +2 more
- one dose of the study SARS-CoV-2 mRNA Vaccine (SYS6006)
- +3 more
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Aug 9, 2022
Under Invasive Mechanical Ventilation in SARS-CoV-2 &
Not yet recruiting
- ARDS Due to Disease Caused by SARS Co-V-2
- +2 more
- (no location specified)
Feb 1, 2023
Long-Term Sequelae of SARS-COV-2 Infection: Diabetes Mellitus
Not yet recruiting
- COVID-19
- Diabete Mellitus
- Measure of physiologic parameters
-
San Antonio, TexasTexas Diabetes Institute - University Health System
May 17, 2023
SARS-CoV-2 Trial (LVRNA009, 0.9%NaCl)
Not yet recruiting
- SARS-CoV-2
- LVRNA009
- 0.9%NaCl
- (no location specified)
Jan 11, 2023
a Randomized Double-blind Study, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), PHYTOTHERAPIE Trial in Sahloul
Completed
- a Randomized Double-blind Study
- +2 more
-
Sahloul, Sousse, TunisiaRiadh Boukef
Jan 2, 2023
Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)
Completed
- Zinc Deficiency
- Sars-CoV-2 Infection
- Zinc Acetate
-
Barcelona, SpainHospital del Mar
Mar 18, 2023
Long COVID Symptoms in SARS-CoV-2-positive Children in China
Active, not recruiting
- Symptoms and Signs
- SBQ-LC survey
-
Beijing, ChinaCapital Institute of Pediatrics
Feb 13, 2023
SARS-CoV Infection, Coronavirus, Corona Virus Infection Trial in Copenhagen (An Oropharyngeal swab)
Recruiting
- SARS-CoV Infection
- +2 more
- An Oropharyngeal swab
-
Copenhagen, Hillerød, Denmark
- +1 more
Jan 10, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- SARS-CoV-2 Antigen-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jul 13, 2022
SARS-CoV2 Infection Trial in Renton (HDT-301)
Active, not recruiting
- SARS-CoV2 Infection
- HDT-301
-
Renton, WashingtonRainier Clinical Research
Jan 16, 2023
NIH RECOVER Tissue Pathology: Understanding Long-Term Impact of
Recruiting
- COVID-19
- SARS CoV 2 Infection
-
New York, New YorkNYU Langone Health
Jan 25, 2023
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Using TSPO
Recruiting
- Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection
- PET Tracer
- +2 more
-
New York, New YorkNYU Langone Health
Nov 7, 2022
SARS (Severe Acute Respiratory Syndrome) Trial in Sousse, Sahloul (Quercetin, Placebo)
Completed
- SARS (Severe Acute Respiratory Syndrome)
- Quercetin
- Placebo
-
Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
- +1 more
Jan 2, 2023
SARS-COV2 Pandemic Serosurvey in a Rare Disease Population
Completed
- SARS-COV2 Virus
-
Bethesda, Maryland
- +1 more
Dec 16, 2022